124
Participants
Start Date
March 31, 2016
Primary Completion Date
December 31, 2022
Study Completion Date
June 30, 2025
Pomalidomide
Chemotherapy
Dexamethasone
Chemotherapy
Cyclophosphamide
Chemotherapy
Belfast Health & Social Care Trust, Belfast
University of Birmingham NHS Foundation Trust, Birmingham
Birmingham Heartlands Hospital, Birmingham
Royal Sussex County Hospital, Brighton
Queens Hospital, Burton-on-Trent
University Hospital of Wales NHS Trust, Cardiff
Ninewells Hospital, Dundee
Beatson Oncology Centre, Glasgow
St James's Hopsital, Leeds
University Hospital of Leicester NHS Trust, Leicester
St Bartholomew Hospital, London
University College London Hospital, London
Guy's and St Thomas' NHS Foundation Trust, London
The Royal Marsden NHS Foundation Trust, London
Imperial College Hospital, London
Central Manchester Univeristy Hospital NHS Trust, Manchester
The Christie Hospital, Manchester
Churchill Hospital, Oxford
Sheffield Teaching Hospitals NHS FoundationTrust, Sheffield
University Hospital of North Tees, Stockton-on-Tees
New Cross Hospital, Wolverhampton
Collaborators (1)
Myeloma UK
OTHER
Celgene
INDUSTRY
University of Leeds
OTHER